ARCH Venture Partners XII, LLC, Ten Percent Owner at Neumora Therapeutics, Inc., holds 3.73M shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 15.46M shares in Prime Medicine, Inc. (Ticker: PRME), holds 31.93M shares in Neumora Therapeutics, Inc. (Ticker: NMRA).
What was ARCH Venture Partners XII, LLC’s latest transaction?
ARCH Venture Partners XII, LLC latest transaction was an Uninformative Buy of ―.
What was ARCH Venture Partners XII, LLC's most profitable transaction?
ARCH Venture Partners XII, LLC’s most profitable transaction was an Informative Buy of NMRA stock on September 25, 2023. The return on the trade was -13.10%.
What is ARCH Venture Partners XII, LLC's role in Neumora Therapeutics, Inc.?
ARCH Venture Partners XII, LLC's role in Neumora Therapeutics, Inc. is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.